SCHEMBL17099250

SCHEMBL17099250

CCOC(=O)C1(CC)CCC(n2ncc(C(=O)OCc3ccccc3)c2C(F)(F)F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.41
MEN1 O00255 6/20 0.41
KDM4E B2RXH2 5/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
LMNA P02545 3/20 0.39
POLB P06746 3/20 0.39
PKM P14618 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
NPY1R P25929 1/20 0.38
TRPC1 P48995 1/20 0.37
TRPC3 Q13507 1/20 0.37
STIM1 Q13586 1/20 0.37
ORAI1 Q96D31 1/20 0.37
STIM2 Q9P246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099245 1.00 KMT2A (0.41) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17099248 1.00 KMT2A (0.41) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17097834 0.90 KDM4E (0.41) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17048961 0.86 GAA (0.36) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17099049 0.86 GAA (0.36) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17099050 0.86 GAA (0.36) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17097953 0.85 KDM4E (0.40) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17118067 0.85 TRPC1 (0.37) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17098886 0.84 KDM4E (0.45) KMT2AMEN1KDM4EMAPTHPGD
SCHEMBL17098883 0.84 KDM4E (0.45) KMT2AMEN1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365522-B2 Pyrazole amide derivative AMGEN INC. (US) 2016-06-14 US disclosed
US-20150266824-A1 Pyrazole Amide Derivative TEIJIN LIMITED (JP) 2015-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150266824-A1 Pyrazole Amide Derivative RORC, RORB, RORA KMT2A 1635/4885MEN1 4091/4885KDM4E 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.